Butler/Till

Trying to find needles in haystacks is an apt metaphor for marketers of rare-disease pharmaceuticals when the only choice is low-value, mass-market television. But advanced TV targeting has brought such companies to “an inflection point,” says Butler/Till’s Scott Ensign. The VP of Digital Media at the Rochester NY agency explains how things have changed and […]